Father Alex Frost is one of many people pushing for the drug to be reclassified from class B to class A. | ITV News Granada ...

The addition of Scott to the Fortrea team while Oren becomes fully dedicated to the medical and scientific aspects of development is a win for clients,” said Anshul Thakral, CEO. “Working closely with ...

Inaugural MHS-AA cohort begins training in Joplin to help meet growing regional and national demand for anesthesia ...

Kansas City University has welcomed its first class of students to its Master of Health Science in Anesthesiologist Assistant program at its Joplin, Mo., campus. According to a Feb. 5 news release, ...

Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, ...

Dewpoint Therapeutics, Inc., a biotechnology company pioneering condensate-modulating therapeutics, today announced the ...

Adds to executive focus on early clinical development and deepens medical and scientific partnership with clientsDURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the "Company"), ...

Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer Brings deep expertise in immunology, oncology and pharmacology with a strong track record ...

Which university is known as Ole Miss? Discover the history, location, academics, and legacy of the University known as Ole ...

ForeBatten Foundation launches national campaign to fund Batten disease research This campaign turns a birthday ...

InflaRx (NASDAQ:IFRX) highlighted progress on its oral C5a receptor 1 (C5aR) antagonist izicopan and outlined upcoming ...

Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant ...